Nitroglycerin vs Nivolumab
Nitroglycerin vs Nivolumab: Overview
This comparison examines the pharmacological differences between Nitroglycerin and Nivolumab.
Mechanism of Action
Nitroglycerin: Nitric oxide donor causing venous and arterial vasodilation.
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pharmacokinetics
Half-life: Nitroglycerin β 1-4 minutes; Nivolumab β 27 days.
Chemical Properties
Molecular Formula: Nitroglycerin β C3H5N3O9.
Molecular Weight: Nitroglycerin β 227.0870 g/mol.
Type: Nitroglycerin β Small molecule; Nivolumab β Antibody.